| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.CDD.4400918 |
| P953 | full work available online at | http://www.nature.com/articles/4400918 |
| http://www.nature.com/articles/4400918.pdf | ||
| P698 | PubMed publication ID | 11687883 |
| P2093 | author name string | S. Benchimol | |
| P2860 | cites work | GADD45 induction of a G2/M cell cycle checkpoint | Q22009111 |
| ei24, a p53 response gene involved in growth suppression and apoptosis | Q22010923 | ||
| LRDD, a novel leucine rich repeat and death domain containing protein | Q22254132 | ||
| Mediation of c-Myc-induced apoptosis by p53. | Q41441186 | ||
| p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes | Q41454039 | ||
| Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. | Q41563742 | ||
| Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis | Q41563751 | ||
| p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. | Q41723055 | ||
| A transactivation-deficient mouse model provides insights into Trp53 regulation and function | Q41759568 | ||
| Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice | Q42484376 | ||
| Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition | Q53425055 | ||
| Induction of apoptosis in HeLa cells by trans-activation-deficient p53 | Q53461564 | ||
| Transcriptional activation by p53 correlates with suppression of growth but not transformation | Q53468212 | ||
| p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells | Q71618789 | ||
| p53-dependent apoptosis suppresses tumor growth and progression in vivo | Q72149266 | ||
| The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter | Q73694178 | ||
| Signaling to p53: breaking the MDM2-p53 circuit | Q77430977 | ||
| p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 | Q24290402 | ||
| PUMA induces the rapid apoptosis of colorectal cancer cells | Q24291462 | ||
| PUMA, a novel proapoptotic gene, is induced by p53 | Q24291463 | ||
| A model for p53-induced apoptosis | Q24313374 | ||
| The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression | Q24533291 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis | Q28144256 | ||
| Definition of a consensus binding site for p53 | Q28207794 | ||
| KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene | Q28250929 | ||
| 14-3-3sigma is a p53-regulated inhibitor of G2/M progression | Q28276061 | ||
| The complexity of p53 modulation: emerging patterns from divergent signals | Q28284854 | ||
| Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
| Bax suppresses tumorigenesis and stimulates apoptosis in vivo | Q28506493 | ||
| Bax-deficient mice with lymphoid hyperplasia and male germ cell death | Q28589360 | ||
| A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 | ||
| Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 | Q29622924 | ||
| Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis | Q33886271 | ||
| Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo | Q33886276 | ||
| Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis | Q33916603 | ||
| Sequence-specific transcriptional activation is essential for growth suppression by p53. | Q35086763 | ||
| p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage | Q35123816 | ||
| p53 and E2F-1 cooperate to mediate apoptosis | Q35185411 | ||
| Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53 | Q35205701 | ||
| Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis | Q35885582 | ||
| p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs | Q36401199 | ||
| Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression | Q36551292 | ||
| Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest | Q36555730 | ||
| Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin | Q36675415 | ||
| Identification and classification of p53-regulated genes | Q36747355 | ||
| Identification of a Novel p53 Functional Domain That Is Necessary for Mediating Apoptosis | Q38337319 | ||
| Wild-type p53 negatively regulates the expression of a microtubule-associated protein | Q41148864 | ||
| Essential role for p53-mediated transcription in E1A-induced apoptosis | Q41302308 | ||
| Growth factor modulation of p53-mediated growth arrest versus apoptosis | Q41365779 | ||
| Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. | Q41414258 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | regulation of gene expression | Q411391 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 1049-1051 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Cell Death & Differentiation | Q2943974 |
| P1476 | title | p53-dependent pathways of apoptosis | |
| P478 | volume | 8 |
| Q42716285 | 7,3′,4′-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species |
| Q35099489 | A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect |
| Q47200013 | Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas |
| Q41348862 | Albendazole as a promising molecule for tumor control. |
| Q33850934 | All-trans-retinal induces Bax activation via DNA damage to mediate retinal cell apoptosis |
| Q24619270 | An arrayed human genomic library constructed in the PAC shuttle vector pJCPAC-Mam2 for genome-wide association studies and gene therapy |
| Q33509737 | Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells |
| Q44289592 | Apoptosis in human hepatoma HepG2 cells induced by corn peptides and its anti-tumor efficacy in H22 tumor bearing mice |
| Q45825211 | Apoptosis of Dalton’s lymphoma due to in vivo treatment with emodin is associated with modulations of hydrogen peroxide metabolizing antioxidant enzymes |
| Q58712148 | Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study |
| Q83014574 | B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation |
| Q35363952 | Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells. |
| Q28771498 | Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression |
| Q24315089 | CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner |
| Q53338395 | Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism |
| Q29617899 | Cellular processing of platinum anticancer drugs |
| Q37142880 | Circadian gene mPer2 overexpression induces cancer cell apoptosis |
| Q64891315 | Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells. |
| Q33186848 | Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability |
| Q36254067 | Crude Extracts, Flavokawain B and Alpinetin Compounds from the Rhizome of Alpinia mutica Induce Cell Death via UCK2 Enzyme Inhibition and in Turn Reduce 18S rRNA Biosynthesis in HT-29 Cells |
| Q38724672 | Cryptolepine, a Plant Alkaloid, Inhibits the Growth of Non-Melanoma Skin Cancer Cells through Inhibition of Topoisomerase and Induction of DNA Damage. |
| Q40203768 | DNA binding and selective gene induction by different forms of the p53 protein |
| Q77099486 | DNA damage and apoptosis |
| Q29248936 | Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells |
| Q41083934 | Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart |
| Q81450104 | Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer |
| Q36013284 | Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response |
| Q35722027 | Honokiol induces cell cycle arrest and apoptosis via p53 activation in H4 human neuroglioma cells |
| Q39588277 | Hot water extract of Chlorella vulgaris induced DNA damage and apoptosis |
| Q61443054 | Impaired non-homologous end joining in human primary alveolar type II cells in emphysema |
| Q39251807 | Imperatorin sensitizes anoikis and inhibits anchorage-independent growth of lung cancer cells |
| Q39354652 | Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma |
| Q35144075 | Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes |
| Q36384554 | Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. |
| Q38760363 | Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells |
| Q38269348 | Leukemia cell microvesicles promote survival in umbilical cord blood hematopoietic stem cells. |
| Q37631153 | Mapping the p53 transcriptome universe using p53 natural polymorphs |
| Q37696270 | Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model |
| Q90334394 | Mechanistic Insight into Size-Dependent Enhanced Cytotoxicity of Industrial Antibacterial Titanium Oxide Nanoparticles on Colon Cells Because of Reactive Oxygen Species Quenching and Neutral Lipid Alteration |
| Q42851591 | Melatonin or silymarin reduces maneb‐ and paraquat‐induced Parkinson’s disease phenotype in the mouse |
| Q33186850 | Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy |
| Q36868501 | N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. |
| Q38866642 | Novel targets for ATM-deficient malignancies |
| Q45345454 | P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma |
| Q36628463 | Period-2: a tumor suppressor gene in breast cancer. |
| Q34303405 | Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis |
| Q45069455 | Regulating MicroRNA Expression: At the Heart of Diabetes Mellitus and the Mitochondrion |
| Q36876734 | Regulation of apoptosis-related genes by nitric oxide in cancer |
| Q35910747 | Role of DNA mismatch repair in apoptotic responses to therapeutic agents |
| Q35934956 | Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by Cotinus coggygria flavonoid nanoliposomes |
| Q35759916 | Sarcophine-Diol, a Skin Cancer Chemopreventive Agent, Inhibits Proliferation and Stimulates Apoptosis in Mouse Melanoma B16F10 Cell Line |
| Q36395785 | Sarcophine-diol inhibits expression of COX-2, inhibits activity of cPLA2, enhances degradation of PLA2 and PLC(γ)1 and inhibits cell membrane permeability in mouse melanoma B16F10 cells. |
| Q47915348 | Spontaneous testicular atrophy occurs despite normal spermatogonial proliferation in a Tp53 knockout rat. |
| Q36432221 | Study of regulatory promoter polymorphism (-248 G>A) of Bax gene in patients with gastric cancer in the northern provinces of Iran |
| Q35865482 | Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo. |
| Q34161230 | TRPC3 cation channel plays an important role in proliferation and differentiation of skeletal muscle myoblasts |
| Q38858580 | The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer |
| Q34094678 | The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma |
| Q38872665 | The nucleoprotein of influenza A virus induces p53 signaling and apoptosis via attenuation of host ubiquitin ligase RNF43. |
| Q34605135 | Thermal stress and cellular signaling processes in hemocytes of native (Mytilus californianus) and invasive (M. galloprovincialis) mussels: Cell cycle regulation and DNA repair |
| Q38651189 | Ultraviolet light-emitting diode irradiation-induced cell death in HL-60 human leukemia cells in vitro |
| Q28073155 | Unraveling the Anticancer Effect of Curcumin and Resveratrol |
| Q36653012 | Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines |
| Q50926666 | miR‐150 promotes the proliferation of lung cancer cells by targeting P53 |
| Q35116655 | p53 downstream targets and chemosensitivity. |
| Q92276564 | p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling |
| Q40635072 | p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells |
| Q53380051 | p53: 25 years of research and more questions to answer. |
Search more.